Oligodendrocytes In Multiple System Atrophy is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Multiple System Atrophy (MSA) is a progressive neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. A defining pathological feature is the presence of glial cytoplasmic inclusions (GCIs) in oligodendrocytes, making it a primary oligodendrogliopathy. [1]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:4042028 | immature neuron |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:4042028 | immature neuron | Medium |
| Feature | Description |
|---|---|
| GCI burden | Correlates with disease severity |
| Neuronal loss | Associated with GCI density |
| Axonal degeneration | Secondary to demyelination |
The study of Oligodendrocytes In Multiple System Atrophy has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Wenning GK, et al. Multiple system atrophy. 2022. ↩︎